A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Clinical trial NCT06351631 · RECRUITING

Trial details

NCT number: NCT06351631
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocythemia, Essential Primary Myelofibrosis Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Polycythemia Vera

Start date: 2024-05-23
Primary completion: 2034-12-04
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.